Waning population immunity to measles in Taiwan (Q39612734)

13 September 2017

Waning population immunity to measles in Taiwan (English)

1 reference

13 September 2017

1 reference

10

Yhu-Chering Huang

1 reference

13 September 2017

Chih-Jung Chen

1

1 reference

13 September 2017

Ping-Ing Lee

2

1 reference

13 September 2017

Yu-Chia Hsieh

3

1 reference

13 September 2017

Po-Yen Chen

4

1 reference

13 September 2017

Yu-Huai Ho

5

1 reference

13 September 2017

Chee-Jen Chang

6

1 reference

13 September 2017

Ding-Ping Liu

7

1 reference

13 September 2017

Feng-Yee Chang

8

1 reference

13 September 2017

Cheng-Hsun Chiu

9

1 reference

13 September 2017

Chin-Yun Lee

11

1 reference

13 September 2017

Tzou-Yien Lin

12

1 reference

13 September 2017

language of work or name

English

0 references

publication date

23 May 2012

1 reference

13 September 2017

1 reference

13 September 2017

30

1 reference

13 September 2017

6721-6727

1 reference

13 September 2017

47

1 reference

Measles, mumps, and rubella in Finland: 25 years of a nationwide elimination programme

13 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.05.019

Measles seroepidemiology and decay rate of vaccine-induced measles IgG titers in Taiwan, 1995-1997.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.05.019

Seroepidemiological study of measles after the 1992 nationwide MMR revaccination program in Taiwan

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.05.019

Measles resurgence in Taiwan---lessons learned

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.05.019

Large outbreak of measles in a community with high vaccination coverage: implications for the vaccination schedule

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.05.019

Summary and conclusions: measles elimination meeting, 16-17 March 2000.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.05.019

International measles incidence and immunization coverage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.05.019

Seroprevalence of measles antibody in the US population, 1999-2004

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.05.019

Low measles seropositivity rate among children and young adults: a sero-epidemiological study in southern China in 2008.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.05.019

Seroprevalence of antibodies to measles, mumps, and rubella among Thai population: evaluation of measles/MMR immunization programme

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.05.019

Development and durability of measles antigen-specific lymphoproliferative response after MMR vaccination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.05.019

Effect of subclinical infection on maintaining immunity against measles in vaccinated children in West Africa

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.05.019

Implications of a 2005 measles outbreak in Indiana for sustained elimination of measles in the United States

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.05.019

Sexual dimorphism of humoral immunity with human vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.05.019

The Xs and Y of immune responses to viral vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.05.019

Persistence of measles, mumps, and rubella antibodies in an MMR-vaccinated cohort: a 20-year follow-up

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.05.019

10.1016/J.VACCINE.2012.05.019

7 January 2021

Identifiers

DOI

1 reference

13 September 2017

1 reference